Consumer Reports: Alzheimer's drugs are costly, ineffective

01/8/2013 | Washington Post, The

Drugs approved to treat Alzheimer's disease are expensive and are not really effective for many patients, according to Consumer Reports Best Buy Drugs. The report said none of the drugs could be considered a "Best Buy," based on analyses from several health care organizations, and that they had side effects that could be debilitating for older patients.

View Full Article in:

Washington Post, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
NGS Provider Enrollment Rep
National Government Services - WellPoint
Harrisburg, PA
Program Manager II
Tufts Health Plan/Network Health
Medford, MA
Director, Medicare Advantage/Medicare Part D Focus
Avalere Health
Washington, DC
Chief, Product Review Branch
FDA/Center for Biologics Evaluation and Research
Silver Spring, MD
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ